Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
171.90    2.20 (1.30%)
Bid:
172.10
Ask:
172.30
Spread: 0.20 (0.116%)
Market Cap: £1.27b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Results of Placing

13 Feb 2020 15:53

RNS Number : 9687C
Grainger PLC
13 February 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

 

 

Grainger plc

("Grainger" or the "Company")

 

 

RESULTS OF PLACING

 

Grainger plc is pleased to announce the successful completion of the placing announced earlier today (the "Placing").

 

A total of 61,200,000 new Ordinary Shares in Grainger (the "Placing Shares") were placed by J.P. Morgan Cazenove and Numis, raising gross proceeds of £186.7 million. Placing Shares have been issued at a price of 305.0 pence per Placing Share. The Placing Shares being issued represent, in aggregate, approximately 9.99 per cent. of Grainger's issued ordinary share capital prior to the Placing.

 

The Placing Price represents a discount of 2.31 per cent. to the closing price on 12 February 2020 of 312.2 pence and a discount of 1.61 per cent. to the intra-day price of 310.0 pence at 11.01 a.m. (being the time the Placing Price was agreed).

 

The Placing Shares will, when issued, be credited as fully paid and rank pari passu with the existing Ordinary Shares, including the right to receive all future dividends and distributions declared, made or paid.

 

Application will be made to the Financial Conduct Authority for admission of the 61,200,000 Placing Shares to the premium listing segment of the Official List maintained by the UK Listing Authority and to London Stock Exchange plc ("LSE") for admission to trading of the Placing Shares on LSE's Main Market for listed securities (together, "Admission"). It is expected that Admission will take place on 17 February 2020 and that dealings in the Placing Shares on the LSE's Main Market for listed securities will commence at the same time.

 

The Placing is conditional, inter alia, upon Admission becoming effective and the Placing Agreement becoming unconditional and not being terminated.

 

Following Admission the total number of voting rights in the Company will be 673,492,299 and 1,506,300 Ordinary Shares are held in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Capitalised terms used but not defined in this announcement have the same meanings as set out in the placing announcement of the Company released at 7.00 a.m. (GMT) on the date hereof.

 

J.P. Morgan Cazenove and Numis acted as joint bookrunners in respect of the Placing.

 

Helen Gordon, Chief Executive Officer of Grainger, commented:

 

 

"We are delighted with the successful outcome of this fundraise which demonstrates the strong support from our shareholders for our ongoing investment in the private rented sector (PRS). This transaction accelerates our PRS growth strategy in London and the regions, and brings forward £246 million of new acquisitions into the secured pipeline, bringing it to c.£1 billion. On completion of the new developments our rental income will grow substantially and this will allow us to further enhance total shareholder returns. We look forward to continuing to deliver quality rental homes in the UK."

 

 

Further enquiries:

 

Grainger plc

Tel: +44 (0) 20 7940 9500

Helen Gordon

Vanessa Simms

 

Kurt Mueller

 

J.P. Morgan Cazenove

Tel: +44 (0) 20 7742 4000

Bronson Albery

 

Barry Meyers

 

Tara Morrison

 

Beau Freker

 

 

Numis

Tel: +44 (0) 20 7260 1000

Heraclis Economides

 

Richard Thomas

 

Ben Stoop

 

George Fry

 

 

Camarco

Tel: +44 (0) 20 3757 4992

Ginny Pulbrook

Geoffrey Pelham Lane

 

Tom Huddart

 

 

 

 

IMPORTANT NOTICE

 

The contents of this announcement have been prepared by and are the sole responsibility of Grainger.

Neither the content of Grainger's website nor any website accessible by hyperlinks on Grainger's website is incorporated in, or forms part of, this announcement.

This announcement is for information purposes only and is directed only at: (a) persons in member states of the EEA who are qualified investors within the meaning of the Prospectus Regulation ("Qualified Investors") (b) persons in the United Kingdom, who are Qualified Investors and (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth companies, unincorporated associations and other persons falling within Article 49(2)(a) to (d) of the Order; and (c) persons to whom it may otherwise by lawfully communicated (all such persons together being referred to as ("Relevant Persons").

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement should not be distributed, forwarded to or transmitted in or into in any jurisdiction where to do so might constitute a violation of local securities laws or regulations, including the United States, Australia, Canada, Japan and South Africa.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. This announcement does not constitute or form part of an offer of securities for sale or solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan, South Africa or in any other jurisdiction in which such offer may be restricted. The securities referred to in this announcement have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state in the United States and may not be offered or sold in the United States, except in reliance on an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will be no public offering of securities in the United States.

Each of J.P. Morgan Cazenove, which is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the Financial Conduct Authority (the "FCA") and the PRA, and Numis (together with J.P. Morgan Cazenove, the "Joint Bookrunners"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no one else in connection with the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to clients of the Joint Bookrunners, nor for providing advice in relation to the Placing or any other matters referred to in this announcement. Neither the Joint Bookrunners nor any of their respective affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, tort or, under statute or otherwise) to any person who is not a client of the Joint Bookrunners in connection with this announcement, any statement contained in herein or otherwise.

This announcement does not constitute a recommendation concerning the Placing. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

Information to Distributors

 

Solely for the purposes of Article 9(8) of Commission Delegated Directive 2017/593 (the "Delegated Directive") regarding the responsibilities of manufacturers under the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that such Placing Shares are: (i) compatible with the target market for the Placing of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all eligible distribution channels for dissemination of the Placing Shares, each as set out in this Announcement, as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares

Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIUOSVRRKUUAAR
Date   Source Headline
11th Jun 20263:12 pmRNSDirector/PDMR Shareholding
9th Jun 20261:25 pmRNSStandard form for notification of major holdings
19th May 20263:50 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSUK Listing Rule 6.4.9R(2) Disclosure
14th May 20263:01 pmRNSCorrection to Dividend Election Date (DRIP)
14th May 20267:00 amRNSHalf Year Financial Results
11th May 20267:00 amRNSGrainger extends core banking facility to 2033
6th May 202611:02 amRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSHolding(s) in Company
20th Apr 20268:00 amRNSShareholder Declarations for gross PIDs
15th Apr 20264:44 pmRNSDirector/PDMR Shareholding
14th Apr 20267:51 amRNSNon-Executive Board Director Appointment
1st Apr 20263:04 pmRNSBlock Listing Return
30th Mar 20267:00 amRNSNotice of Results and Investor Presentation
27th Mar 20261:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:16 pmRNSDirector/PDMR Shareholding
11th Mar 20264:16 pmRNSDirector/PDMR Shareholding
5th Mar 20262:10 pmRNS-RMelloMonday Investor Webinar
4th Mar 20265:02 pmRNSDirector/PDMR Shareholding
4th Mar 20264:44 pmRNSDirector/PDMR Shareholding
10th Feb 20265:33 pmRNSDirector/PDMR Shareholding
4th Feb 20264:07 pmRNSResult of AGM
4th Feb 20267:00 amRNSTrading Update
3rd Feb 20263:24 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSConstruction begins on second Guildford BTR scheme
26th Jan 20267:00 amRNSGrainger JV Acquires 195‑Home Build to Rent Scheme
7th Jan 202612:31 pmRNSStandard form for notification of major holdings
5th Jan 202612:07 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:43 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:43 pmRNSDirector/PDMR Shareholding
22nd Dec 20255:18 pmRNSDirector/PDMR Shareholding
22nd Dec 20255:18 pmRNSDirector/PDMR Shareholding
22nd Dec 20255:17 pmRNSDirector/PDMR Shareholding
22nd Dec 20255:17 pmRNSDirector/PDMR Shareholding
19th Dec 202512:38 pmRNSDirector/PDMR Shareholding
19th Dec 202512:38 pmRNSDirector/PDMR Shareholding
18th Dec 202511:14 amRNSStandard form for notification of major holdings
16th Dec 20252:44 pmRNSPublication of the Notice of AGM 2026
12th Dec 202512:19 pmRNSDirector/PDMR Shareholding
12th Dec 202512:13 pmRNSDirector/PDMR Shareholding
4th Dec 202511:58 amRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSDirector/PDMR Shareholding
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSPreliminary Full Year Financial Results
5th Nov 20251:42 pmRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSStatement on Rent Reform Bill
21st Oct 20257:00 amRNSNotice of Results and Investor Presentation
16th Oct 202510:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.